Advertentbio
2 known investors
Advertent Biotherapeutics is a biotechnology company developing first-in-class biologics that modulate TGF-β family growth factors to protect muscle quality and promote regeneration in neuromuscular disorders, with a particular focus on muscular dystrophies. Founded in 2019 as a spin-out from Michigan State University, it targets high-unmet-need conditions where muscle degeneration and wasting cause disability.
Founders & leadership
MF
Monique FloerCo-Founder, President & CEO
EM
Erik M. Martinez-HackertCo-Founder & CSO
Investors · 2
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $250K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Advertentbio do?
- Advertent Biotherapeutics is a biotechnology company developing first-in-class biologics that modulate TGF-β family growth factors to protect muscle quality and promote regeneration in neuromuscular disorders, with a particular focus on muscular dystrophies. Founded in 2019 as a spin-out from Michigan State University, it targets high-unmet-need conditions where muscle degeneration and wasting cause disability.
- Who founded Advertentbio?
- Advertentbio was founded by Monique Floer, Erik M. Martinez-Hackert.
- Who are Advertentbio's investors?
- Advertentbio's investors include Michigan Rise, WMU Biosciences Research & Commercialization Center.